Navigation Links
Study examines the use of light in medical therapy
Date:3/30/2009

Santiago de Compostela, Spain March 30, 2009 A study published in a special issue of Photochemistry and Photobiology examines the emerging practice of drug delivery systems which use the application of light to activate medications in the body.

The process uses biocompatible materials that are sensitive to certain physiological variables or external physicochemical stimuli. Changes in external or internal body conditions can be used to achieve control of the delivery. There are drug delivery systems that can respond to small changes in light, temperature, pH or the concentration of specific substances.

Current research on the drug delivery systems is focused on developing systems capable of delivering the adequate dose of drug at the target site, avoiding collateral effects and enhancing the therapeutic efficiency. In the case of cancer, light-sensitive systems are particularly useful for direct treatment of malignant cells and minimizing damage to healthy cells.

External control of drug delivery offers a number of advantages. The process enables an easy and precise control of the medication. Switching the light on and off also triggers or stops the release of medication. This can often be done by the patient.

"Near-infrared (NIR) light is particularly useful as an agent capable of triggering the drug release," says Carmen Alvarez-Lorenzo, co-author of the study. "NIR is innocuous, does not cause significant heating in the area of its application and can be useful in the difficult to access areas of the body."


'/>"/>

Contact: Sean Wagner
journalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Study examines effect of heart surgery on employment
2. Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
3. Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers
4. Study Links Sugar Production in Yeast Cells to Longevity
5. Mayo study shows simple finger device may help predict future heart events, such as heart attack
6. Study shows that exercise reduces migraine suffering
7. Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack
8. New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
9. Autism Study Finds Significant Benefit with Hyperbaric Treatment
10. Danon Disease Can Be Quickly Fatal, Study Finds
11. NYU study finds new risk factor for melanoma in younger women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 17, 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene ... vice president, research and pharmaceutical development at Tocagen, will present at ... held Jan. 17-20 in Miami . ... ... manufacturing for replicating viruses - what to do when and why ...
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has ... Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, ... Forecast to 2021" report to their offering. ... The global active pharmaceutical ingredients ... USD 157.95 Billion in 2016, growing at a CAGR of 6.3% ...
(Date:1/17/2017)... , Jan. 17, 2017 Immune Pharmaceuticals (NASDAQ: ... company, announced today that it will hold a Satellite Symposium ... Acute Leukemias (ISAL) XVI in Munich, Germany ... "Reinforcing the Efficacy of Immunotherapy for the maintenance of ... on Monday February 20 th , 2017 from 12:45 – ...
Breaking Medicine Technology: